Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2023 ▲▼ | Q3 2023 ▲▼ | Change ▲▼ | Q2 2023 ▲▼ | Q3 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Olema Pharmaceuticals, Inc.(OLMA) | 462,500 | 1,857,681 | +1,395,181 | 4,176 | 22,942 | 6.12% | +18,766 |
| STRUCTURE THERAPEUTICS INC | 0 | 230,761 | +230,761 | 0 | 11,635 | 3.11% | +11,635 |
| CYMABAY THERAPEUTICS INC | 0 | 610,770 | +610,770 | 0 | 9,107 | 2.43% | +9,107 |
| Avadel Pharmaceuticals PLC | 0 | 664,224 | +664,224 | 0 | 6,842 | 1.83% | +6,842 |
| Crinetics Pharmaceuticals Inc.(CRNX) | 479,053 | 479,053 | 0 | 8,633 | 14,247 | 3.80% | +5,615 |
| MORPHIC HOLDING INC | 0 | 200,000 | +200,000 | 0 | 4,582 | 1.22% | +4,582 |
| Adaptimmune Therapeutics plc | 0 | 5,095,912 | +5,095,912 | 0 | 3,975 | 1.06% | +3,975 |
| VIKING THERAPEUTICS INC(VKTX) | 0 | 325,000 | +325,000 | 0 | 3,598 | 0.96% | +3,598 |
| Repare Therapeutics, Inc. | 1,639,849 | 1,639,849 | 0 | 17,350 | 19,809 | 5.29% | +2,460 |
| Amicus Therapeutics Inc. COM | 516,139 | 716,139 | +200,000 | 6,483 | 8,708 | 2.32% | +2,226 |
| Insmed Incorporated(INSM) | 529,743 | 527,458 | -2,285 | 11,178 | 13,318 | 3.56% | +2,141 |
| Moonlake Immunotherapeutics(MLTX) | 295,111 | 294,190 | -921 | 15,051 | 16,769 | 4.48% | +1,718 |
| Harpoon Therapeutics, Inc. | 0 | 319,670 | +319,670 | 0 | 1,288 | 0.34% | +1,288 |
| Revolution Medicines, Inc.(RVMD) | 273,408 | 273,408 | 0 | 7,314 | 7,568 | 2.02% | +254 |
| Oncorus, Inc. | 2,377,031 | 0 | -2,377,031 | 96 | 0 | — | -96 |
| Axsome Therapeutics, Inc.(AXSM) | 93,586 | 93,586 | 0 | 6,725 | 6,541 | 1.75% | -184 |
| Phathom Pharmaceuticals inc | 282,332 | 347,332 | +65,000 | 4,043 | 3,602 | 0.96% | -441 |
| Inozyme Pharma Inc. | 326,921 | 326,921 | 0 | 1,821 | 1,373 | 0.37% | -448 |
| Ventyx Biosciences Inc | 31,747 | 0 | -31,747 | 1,041 | 0 | — | -1,041 |
| Kalvista Pharmaceuticals Inc | 761,538 | 577,958 | -183,580 | 6,854 | 5,566 | 1.49% | -1,288 |
| Viridian Therapeutics Inc(VRDN) | 255,323 | 255,323 | 0 | 6,074 | 3,917 | 1.05% | -2,157 |
| Werewolf Therapeutics, Inc. | 2,388,011 | 2,388,011 | 0 | 7,283 | 5,110 | 1.36% | -2,173 |
| Harpoon Therapeutics, Inc. | 3,196,707 | 0 | -3,196,707 | 2,270 | 0 | — | -2,270 |
| REGENXBIO Inc. | 656,718 | 656,718 | 0 | 13,128 | 10,810 | 2.89% | -2,318 |
| Karuna Therapeutics Inc | 53,399 | 53,210 | -189 | 11,580 | 8,997 | 2.40% | -2,582 |
| Madrigal Pharmaceuticals inc(MDGL) | 38,011 | 40,859 | +2,848 | 8,781 | 5,967 | 1.59% | -2,813 |
| Xeris Biopharma Holdings Inc | 3,974,999 | 3,987,967 | +12,968 | 10,414 | 7,418 | 1.98% | -2,997 |
| Travere Therapeutics Inc.(TVTX) | 552,846 | 552,846 | 0 | 8,492 | 4,942 | 1.32% | -3,549 |
| iTeos Therapeutics, Inc. | 1,745,943 | 1,745,943 | 0 | 23,116 | 19,118 | 5.10% | -3,998 |
| Verve Therapeutics, Inc | 857,940 | 857,940 | 0 | 16,086 | 11,376 | 3.04% | -4,710 |
| Adaptimmune Therapeutics plc | 5,095,912 | 0 | -5,095,912 | 4,714 | 0 | — | -4,714 |
| Intellia Therapeutics, Inc.(NTLA) | 544,639 | 544,639 | 0 | 22,210 | 17,221 | 4.60% | -4,989 |
| Edgewise Therapeutics Inc(EWTX) | 712,798 | 0 | -712,798 | 5,524 | 0 | — | -5,524 |
| Relay Therapeutics Inc.(RLAY) | 1,354,368 | 1,352,133 | -2,235 | 17,011 | 11,371 | 3.04% | -5,639 |
| Iovance Biotherapeutics Inc(IOVA) | 2,950,118 | 3,287,397 | +337,279 | 20,769 | 14,958 | 3.99% | -5,811 |
| Avadel Pharmaceuticals PLC | 384,990 | 0 | -384,990 | 6,345 | 0 | — | -6,345 |
| Geron Corporation(GERN) | 9,191,290 | 10,712,481 | +1,521,191 | 29,504 | 22,710 | 6.06% | -6,794 |
| Cullinan Oncology, Inc.(CGEM) | 7,648,268 | 7,648,268 | 0 | 82,295 | 69,217 | 18.48% | -13,079 |
| Reata Pharmaceuticals, Inc. | 234,478 | 0 | -234,478 | 23,907 | 0 | — | -23,907 |
| Chinook Therapeutics, Inc. | 1,003,406 | 0 | -1,003,406 | 38,551 | 0 | — | -38,551 |
| Iveric Bio Inc | 1,214,662 | 0 | -1,214,662 | 47,785 | 0 | — | -47,785 |